CME Group (CME) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
21 Oct, 2026Market position and growth
YTD 2026 ADV was 31.8M contracts, including 9.8M international ADV; products span major asset classes with centralized clearing and risk management.
FY2025 set records with $6.5B revenue and 28.1M ADV; 1H26 revenue reached a record $3.6B, up 8%, and adjusted diluted EPS was a record $6.35, up 10%.
1H26 total ADV was 33.0M, up 10%; non-U.S. ADV was 10.3M, up 14%, with growth across EMEA, APAC and Latin America.
1H26 micro crypto products ADV reached a record 5.4M; the crypto suite expanded to 24/7 trading, with compute, Bitcoin Cash, Uniswap and energy-transition products in the pipeline.
Average daily margin savings exceeded $95B in 2Q26 across six asset classes; OTC interest rate swap portfolio margining savings approach $12B per day.
Leadership succession
Lynne Fitzpatrick becomes CEO and joins the board on March 1, 2027; Terrence Duffy becomes Executive Chairman on the same date.
Jack Tobin becomes CFO on March 1, 2027, following a Deputy CFO overlap beginning November 2026; he has served as Chief Accounting Officer since 2015.
John Marchese was promoted to Senior Managing Director and General Counsel in September 2026.
Board and governance
The board is 95% independent, with 12 years average tenure and 26% gender diversity; independent Lead Director Charles P. Carey has held the role since May 2025.
Board committees oversee audit, compensation, finance, clearing house risk, market regulation, enterprise risk, governance and strategic initiatives; risk and CISO reporting to the board is quarterly.
2026 routine vote support was 91.7% for equity director elections, 91.5% for auditor ratification and 88.0% for say on pay; Class B election-rights elimination proposals received 27.8%, 23.4% and 16.4%.
Class B reform proposals failed to secure the required majority of affected outstanding shares despite 50+ outreach meetings; ownership fragmentation and voter apathy were cited as challenges.
Governance practices include annual director elections, fully independent principal standing committees, annual board effectiveness assessment and a cybersecurity program aligned with NIST.
Latest events from CME Group
- Record Q3 revenue and ADV, with adjusted EPS up 13% and ~$1B returned.CME
Q3 2026 - Q2 2026 revenue up 1% to $1.7B, with record market data and strong shareholder returns.CME
Q2 2026 - S&P 500 ESG Index rebranded as Scores and Screens, fueling growth in liquid ESG investment products.CME
Beyond ESG with Understanding the S&P 500 ESG Index Ecosystem Conference - Strong volumes, new product launches, and tech-driven change shape a dynamic market outlook.CME
Piper Sandler Global Exchange and Trading Conference 2024 - Director election amendments failed; all nominated directors reelected; no shareholder questions.CME
AGM 2026 - CFTC's Bitcoin perpetual approval sparks risk warnings amid new product launches and efficiency focus.CME
Piper Sandler Global Exchange and Fintech Conference - Record Q1 2026 revenue and net income driven by surging global trading volumes and innovation.CME
Q1 2026 - Record revenue, earnings, and trading volumes, with strong innovation and capital returns.CME
Q4 2025 - Record Q2 revenue, net income, and trading volumes with broad-based growth and innovation.CME
Q2 2024